HEADER ANTIBIOTIC 29-OCT-24 9KAR TITLE SOLUTION NMR STRUCTURE OF A NEW LASSO PEPTIDE STREPTACIDIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLY-GLY-TRP-GLY-THR-VAL-PRO-ASP-TRP-PHE-PHE-ASN-MET-ASN- COMPND 3 TRP; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: 15-MER LASSO PEPTIDE STREPTACIDIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTACIDIPHILUS JIANGXIENSIS; SOURCE 3 ORGANISM_TAXID: 235985; SOURCE 4 STRAIN: CGMCC 4.1857; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSSETTA; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCDFDUET-1 KEYWDS LASSO PEPTIDE, TOPOLOGICAL STRUCTURE, SOLUTION NMR STRUCTURE, RIPPS, KEYWDS 2 ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR J.W.HUANG,C.Y.CAO REVDAT 1 16-APR-25 9KAR 0 JRNL AUTH J.HUANG,B.CHENG,C.CAO,W.LIU JRNL TITL GENOME MINING AND HETEROLOGOUS EXPRESSION REVEAL JRNL TITL 2 STREPTACIDIN, A NEW LASSO PEPTIDE FROM STREPTACIDIPHILUS JRNL TITL 3 JIANGXIENSIS. JRNL REF ORG.BIOMOL.CHEM. V. 23 1723 2025 JRNL REFN ESSN 1477-0539 JRNL PMID 39807060 JRNL DOI 10.1039/D4OB01998A REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9KAR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 01-NOV-24. REMARK 100 THE DEPOSITION ID IS D_1300053182. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NA REMARK 210 PRESSURE : 101K PA REMARK 210 SAMPLE CONTENTS : 30 MG/ML NONE STREPTACIDIN, DMSO REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRFAM-SPARKY 1.470 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-15 REMARK 470 RES CSSEQI ATOMS REMARK 470 ASP A 8 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY A 1 CG ASP A 8 1.29 REMARK 500 H GLY A 2 O ASN A 12 1.59 REMARK 500 N GLY A 1 OD1 ASP A 8 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TRP A 3 78.53 47.16 REMARK 500 1 THR A 5 -77.70 -155.82 REMARK 500 1 ASP A 8 -158.95 -161.64 REMARK 500 1 PHE A 11 -71.51 -147.54 REMARK 500 2 TRP A 3 77.32 46.14 REMARK 500 2 THR A 5 -67.89 -153.91 REMARK 500 2 ASP A 8 -154.13 -146.23 REMARK 500 2 PHE A 11 -77.68 -155.11 REMARK 500 3 TRP A 3 78.47 46.89 REMARK 500 3 THR A 5 -76.58 -155.11 REMARK 500 3 ASP A 8 -162.59 -162.92 REMARK 500 3 PHE A 11 -69.32 -148.66 REMARK 500 4 TRP A 3 78.48 48.42 REMARK 500 4 THR A 5 -71.96 -153.82 REMARK 500 4 ASP A 8 -153.02 -146.91 REMARK 500 4 PHE A 11 -74.30 -146.01 REMARK 500 5 TRP A 3 80.51 43.32 REMARK 500 5 THR A 5 -75.94 -154.08 REMARK 500 5 ASP A 8 -157.37 -146.53 REMARK 500 5 PHE A 10 -70.06 -75.55 REMARK 500 5 PHE A 11 -78.17 -144.97 REMARK 500 6 TRP A 3 76.53 49.32 REMARK 500 6 THR A 5 -77.10 -151.24 REMARK 500 6 PHE A 11 -79.11 -145.99 REMARK 500 7 TRP A 3 78.18 47.93 REMARK 500 7 THR A 5 -62.39 -152.62 REMARK 500 7 ASP A 8 -151.79 -145.82 REMARK 500 7 PHE A 11 -79.66 -145.08 REMARK 500 8 TRP A 3 83.46 46.88 REMARK 500 8 THR A 5 -75.86 -151.96 REMARK 500 8 PHE A 11 -76.68 -146.61 REMARK 500 9 TRP A 3 89.30 40.92 REMARK 500 9 THR A 5 -78.54 -151.11 REMARK 500 9 ASP A 8 -151.94 -145.29 REMARK 500 9 PHE A 11 -77.44 -145.18 REMARK 500 10 TRP A 3 76.98 47.70 REMARK 500 10 THR A 5 -75.01 -152.51 REMARK 500 10 PHE A 10 -71.92 -76.64 REMARK 500 10 PHE A 11 -70.21 -144.15 REMARK 500 11 TRP A 3 83.37 45.32 REMARK 500 11 THR A 5 -82.29 -154.93 REMARK 500 11 ASP A 8 -167.75 -160.01 REMARK 500 11 PHE A 11 -73.28 -148.92 REMARK 500 12 TRP A 3 83.12 43.68 REMARK 500 12 THR A 5 -72.74 -153.80 REMARK 500 12 PHE A 11 -79.80 -149.49 REMARK 500 13 TRP A 3 85.72 43.24 REMARK 500 13 THR A 5 -75.30 -152.99 REMARK 500 13 PHE A 11 -68.86 -148.29 REMARK 500 14 TRP A 3 81.67 47.10 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36701 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF A NEW LASSO PEPTIDE STREPTACIDIN DBREF 9KAR A 1 15 PDB 9KAR 9KAR 1 15 SEQRES 1 A 15 GLY GLY TRP GLY THR VAL PRO ASP TRP PHE PHE ASN MET SEQRES 2 A 15 ASN TRP CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MASTER 158 0 0 0 0 0 0 6 129 1 0 2 END